Hepion Pharmaceuticals, Inc.
HEPA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,321 | $2,924 | $4,586 | $406 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,419 | $1,581 | $1,732 | $1,207 |
| Total Curr. Assets | $3,740 | $4,505 | $6,319 | $1,614 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,740 | $4,505 | $6,319 | $1,614 |
| Liabilities | – | – | – | – |
| Payables | $77 | $173 | $243 | $220 |
| Short-Term Debt | $214 | $372 | $526 | $2,900 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $56 | $48 | $166 | $24 |
| Total Curr. Liab. | $347 | $593 | $936 | $3,144 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $68 | $116 | $1,487 | $333 |
| Total NC Liab. | $68 | $116 | $1,487 | $333 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $416 | $709 | $2,422 | $3,477 |
| Equity | – | – | – | – |
| Pref Stock | $1,695 | $1,695 | $1,695 | $1,695 |
| Common Stock | $1 | $1 | $1 | $0 |
| Retained Earnings | -$245,440 | -$244,968 | -$243,926 | -$237,820 |
| AOCI | $8 | $8 | $8 | $8 |
| Other Equity | $247,060 | $247,061 | $246,117 | $234,253 |
| Total Equity | $3,324 | $3,797 | $3,896 | -$1,863 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,740 | $4,505 | $6,319 | $1,614 |
| Net Debt | -$2,107 | -$2,553 | -$4,060 | $2,494 |